Overview Dividends

(INGR) Ingredion - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4571871023

Starches, Sweeteners, Corn Oil, Gluten Feed, Biomaterials

Agricultural Products & Services
Market Cap in USD: 6,865m

IPO / Inception: 1997-12-11
Return 12m vs S&P 500: -35.3%

EPS (Earnings per Share)

EPS CAGR: 27.99%
EPS Trend: 76.9%

Last SUE: -0.80
Qual. Beats: 0

Revenue

Rev. CAGR: 0.92%
Rev. Trend: -44.3%

Last SUE: -2.09
Qual. Beats: 0

Dividends

Dividend Yield	2.99%
Yield on Cost 5y	4.80%
Yield CAGR 5y	-1.82%
Payout Consistency	96.0%
Payout Ratio	28.7%

Risk via 10d forecast
Volatility	19.1%
Value at Risk 5%th	29.4%
Relative Tail Risk	-6.54%

Reward TTM
Sharpe Ratio	-1.65
Alpha	-32.40
CAGR/Max DD	0.20

Character TTM
Hurst Exponent	0.514
Beta	0.306
Beta Downside	0.214

Drawdowns 3y
Max DD	29.95%
Mean DD	7.67%
Median DD	5.42%

Description: INGR Ingredion November 03, 2025

Ingredion Incorporated (NYSE: INGR) manufactures and markets a broad portfolio of corn-derived ingredients-including sweeteners, starches, nutrition ingredients, and biomaterial solutions-serving food & beverage, paper, textile, construction, pharmaceutical, cosmetics, and specialty industrial markets worldwide. Its product set spans everything from glucose syrups and high-fructose corn syrup to specialty starches for biodegradable plastics and water-filtration applications.

Key metrics and sector drivers: In fiscal 2023 the company generated roughly $6.5 billion in revenue with an adjusted EBITDA margin near 10 %, reflecting strong pricing power in high-growth “clean-label” and plant-based food segments. Ingredient demand is closely tied to corn commodity prices and global food-security trends, while end-market exposure to the expanding snack-and-convenience sector underpins volume growth. Additionally, Ingredion’s recent acquisitions in the specialty bioplastics space aim to capture a projected $45 billion market opportunity by 2030.

For a deeper quantitative view of INGR’s valuation and risk profile, you may find the ValueRay platform useful.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (659.0m TTM) > 0 and > 6% of Revenue (6% = 435.7m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA -4.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 30.82% (prev 27.76%; Δ 3.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 975.0m > Net Income 659.0m (YES >=105%, WARN >=100%)

Net Debt (883.0m) to EBITDA (1.18b) ratio: 0.75 <= 3.0 (WARN <= 3.5)

Current Ratio 2.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (65.4m) change vs 12m ago -1.65% (target <= -2.0% for YES)

Gross Margin 25.43% (prev 23.07%; Δ 2.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 94.57% (prev 100.3%; Δ -5.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 25.84 (EBITDA TTM 1.18b / Interest Expense TTM 37.0m) >= 6 (WARN >= 3)

Altman Z'' 6.34

(A) 0.29 = (Total Current Assets 3.52b - Total Current Liabilities 1.28b) / Total Assets 7.83b

(B) 0.70 = Retained Earnings (Balance) 5.50b / Total Assets 7.83b

(D) 1.28 = Book Value of Equity 4.55b / Total Liabilities 3.57b

Total Rating: 6.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 73.05

1. Piotroski 6.50pt

2. FCF Yield 10.90%

3. FCF Margin 11.62%

4. Debt/Equity 0.42

5. Debt/Ebitda 0.75

6. ROIC - WACC (= 5.84)%

7. RoE 16.10%

8. Rev. Trend -44.32%

9. EPS Trend 76.95%

What is the price of INGR shares?

As of November 28, 2025, the stock is trading at USD 107.58 with a total of 643,551 shares traded.
Over the past week, the price has changed by +0.58%, over one month by -8.43%, over three months by -15.43% and over the past year by -25.91%.

Is INGR a buy, sell or hold?

Ingredion has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold INGR.

Strong Buy: 1
Buy: 1
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the INGR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	124.3	15.6%
Analysts Target Price	124.3	15.6%
ValueRay Target Price	103.3	-3.9%

INGR Fundamental Data Overview November 21, 2025

Market Cap USD = 6.86b (6.86b USD * 1.0 USD.USD)
P/E Trailing = 10.7067
P/E Forward = 9.4429
P/S = 0.9453
P/B = 1.5883
P/EG = 1.1245
Beta = 0.706
Revenue TTM = 7.26b USD
EBIT TTM = 956.0m USD
EBITDA TTM = 1.18b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 57.0m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 883.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.74b USD (6.86b + Debt 1.80b - CCE 921.0m)
Interest Coverage Ratio = 25.84 (Ebit TTM 956.0m / Interest Expense TTM 37.0m)
FCF Yield = 10.90% (FCF TTM 844.0m / Enterprise Value 7.74b)
FCF Margin = 11.62% (FCF TTM 844.0m / Revenue TTM 7.26b)
Net Margin = 9.07% (Net Income TTM 659.0m / Revenue TTM 7.26b)
Gross Margin = 25.43% ((Revenue TTM 7.26b - Cost of Revenue TTM 5.42b) / Revenue TTM)
Gross Margin QoQ = 25.06% (prev 26.02%)
Tobins Q-Ratio = 0.99 (Enterprise Value 7.74b / Total Assets 7.83b)
Interest Expense / Debt = 0.39% (Interest Expense 7.00m / Debt 1.80b)
Taxrate = 28.63% (69.0m / 241.0m)
NOPAT = 682.3m (EBIT 956.0m * (1 - 28.63%))
Current Ratio = 2.75 (Total Current Assets 3.52b / Total Current Liabilities 1.28b)
Debt / Equity = 0.42 (Debt 1.80b / totalStockholderEquity, last quarter 4.24b)
Debt / EBITDA = 0.75 (Net Debt 883.0m / EBITDA 1.18b)
Debt / FCF = 1.05 (Net Debt 883.0m / FCF TTM 844.0m)
Total Stockholder Equity = 4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.41% (Net Income 659.0m / Total Assets 7.83b)
RoE = 16.10% (Net Income TTM 659.0m / Total Stockholder Equity 4.09b)
RoCE = 16.39% (EBIT 956.0m / Capital Employed (Equity 4.09b + L.T.Debt 1.74b))
RoIC = 11.55% (NOPAT 682.3m / Invested Capital 5.91b)
WACC = 5.72% (E(6.86b)/V(8.66b) * Re(7.14%) + D(1.80b)/V(8.66b) * Rd(0.39%) * (1-Tc(0.29)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.76%
[DCF Debug] Terminal Value 74.55% ; FCFE base≈969.2m ; Y1≈774.5m ; Y5≈524.6m
Fair Price DCF = 153.4 (DCF Value 9.75b / Shares Outstanding 63.5m; 5y FCF grow -24.05% → 3.0% )
EPS Correlation: 76.95 | EPS CAGR: 27.99% | SUE: -0.80 | # QB: 0
Revenue Correlation: -44.32 | Revenue CAGR: 0.92% | SUE: -2.09 | # QB: 0

Additional Sources for INGR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle